ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Eli Lilly's earnings, sales guidance for 2020 tops estimates firstwordpharma
December 17, 2019Eli Lilly said Tuesday that it expects earnings per share next year in the range of $6.70 to $6.80, with overall revenue between of $23.6 billion and $24.1 billion, driven by growth from key products such as Taltz and Trulicity.
Pharma Sources Insight January 2025
